Diagnostics & Imaging
EchoNext
FDA-cleared cardiovascular AI analyzing compatible 12-lead ECGs to flag possible structural heart disease for follow-up.
The Signal
Cleared under K260332 on June 8, 2026. Supports referral and further assessment rather than confirming a diagnosis. Pathway's OpenEvidence partnership was announced in June, not October.
Company profileMore in Diagnostics & Imaging
Aidoc
AI-powered triage and notification software for radiologists and clinical imaging workflows.
View toolViz.ai
AI platform that detects stroke and vascular diseases, alerting care teams instantly.
View toolLunit
AI software for cancer detection in chest x-rays and mammography images.
View toolPaige AI
AI-native digital pathology viewer and diagnostic software for cancer detection.
View tooliRhythm
Ambulatory cardiac monitoring service using wearable patches and AI analysis.
View toolPathAI
Machine learning pathology tools for precise cancer diagnosis and drug development.
View tool